non-specific chronic low back pain. Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18-50 Permanent or intermittent local pain between L1 to gluteal fold without any radicular pain for 3 months or more and between 3-7/10 based on Numeric Rating Scale (NRS) Disability based on Oswestry Disability Index (ODI) between 20-60 Fear of movement based on Tampa scale for kinesiophobia>37 Minimum level of education Native Persian speaking
Exclusion criteria
Exclusion criteria: Any evidence of e specific medical diagnosis include spondylolisthesis, fracture, tumor or inflammation disease Rheumatoid disease,fibromyalgia, neuropathy, Progressive neurological disease History of headache, dizziness, nausea, epilepsy, migraines and mental disorders History of lumbar surgery in the past 3 years Beck’s Anxiety Inventory> 26 Beck's Depression Inventory II> 29 Pregnancy Having other therapies during the present research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the study, end of 6 weeks of treatment, 1 and 4 months follow-up. Method of measurement: Numeric Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fear Avoidance Believes. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Fear Avoidance Believes questionnaire.;Kinesiophobia. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Tampa scale of kinesiophobia.;Pain Catastrophizing. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Pain Catastrophizing Scale.;Disability. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Oswestry disability scalequestionnaire.;Forward flexion ROM. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Tape.;Absolute power of frequency spectrum. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Electroencephalography.;Relative power of the frequency spectrum. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Electroencephalography.;Quality of Life. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Sf36 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences